Clean steel-low-carbon steelmaking
Partnership website: https://www.estep.eu/clean-steel-partnership/
The Clean Steel Partnership (CSP) is aligned with the EU’s goal and policies to achieve climate neutrality by 2050 – the European Green Deal, the Clean Planet for All strategy and the Paris Agreement. It will thus contribute to fighting climate change and moving towards climate neutrality by 2050.
CSP will develop lean CO2 technologies, and test these at large scales until 2030. These technologies are required to reduce CO2 from EU steel production by 80-95% compared to 1990 levels, ultimately leading to climate neutrality.
CSP will ensure a coordinated, sustainable approach across stakeholders, technologies, production routes and countries.
CSP nurtures the long-term vision of supporting the European leadership in the transformation of the steel industry into a climate neutral sector while preserving the competitiveness and viability of the EU steel industry making sure that EU
production will be able to meet the growing demand for steel products.
By 2027 it will implement at least 2 demonstration projects leading to a 50% reduction in CO2 emissions and achieve technology readines level 8 by 2030 in at least 12 areas funded by the partnership.
The EU Clean Steel Partnership (CSP) has started in June 2021 in the Frame of Horizon Europe in synergy with the Research Fund for Coal and Steel (RFCS). The public and private side agreed on a dedicated Memorandum of Understanding (MoU). The public side is represented by DG RTD and DG Grow while the private side is represented by ESTEP. The main decision body for CSP is the Partnershipboard.
Contact
Partners: ESTEP - sg@estep.eu
What are partnerships?
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
How to use partnerships?
-
orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points. -
networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents. -
ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain. -
steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
